Funds with similar focus
| Fund Name | Location |
| ADV | England, London, United Kingdom |
| Autobot Capital Partners | Beijing, Beijing, China |
| Business Angels Switzerland (BAS) | Switzerland, Zürich, Zurich |
| Frontline BioVentures | China, Shanghai |
| Futury Ventures | - |
| Global Health & Pharma | East Staffordshire, England, United Kingdom |
| Guangdong Songfa Ceramics | Chaozhou, China, Guangdong Province |
| Hacking Health Accelerator | Canada, Montréal, Quebec |
| IT Farm | Chiyoda, Japan |
| Liberty Financial | Australia, Melbourne, Victoria |
| McDonnell Ventures | - |
| PhillipCapital | Central, Central Region, Singapore |
| Rowan University | Glassboro, New Jersey, United States |
| Securian Ventures | Minnesota, Saint Paul, United States |
| Sunrise Strategic Partners | Boulder, Colorado, United States |
| Swarth Group | - |
| Trend Discovery Capital Management | New York, New York, United States |
| Xian Aerospace Base International Incubator | China, Shaanxi, Xian Shi |
| XLerateHealth | Kentucky, Louisville, United States |
| Zhonghui Guoji | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
CrossLend | $16M | 06 Sep 2018 | Berlin, Berlin, Germany |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
CrossLend | $16M | 06 Sep 2018 | Berlin, Berlin, Germany |
